LOTUSEYE · Healthcare · Medical Care Facilities
Composite scorecard: 28/100 — Quality 16 · Valuation 2 · Momentum 100
| Share price | ₹121.42 |
| Market cap | ₹246 Cr |
| P/B ratio | 4.2 |
| ROE | 0.4% |
| ROCE | 1.1% |
| Book value | ₹28.23 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹54 Cr | ₹0 Cr | -0.7% |
| 2025 | ₹50 Cr | ₹1 Cr | 0.9% |
| 2024 | ₹47 Cr | ₹3 Cr | 6.2% |
| 2023 | ₹46 Cr | ₹4 Cr | 10.2% |
| 2022 | — | — | — |
Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE, a refractive lenticule extraction small incision lenticule extraction; touch free laser; lasik eye surgery; Epi-LASIK, an epithelial laser in situ keratomileusis; Intralase, a blade-free technique to create the corneal flap; Zyoptix Supracor laser technology; robotic femto laser cataract surgery; phacoemulsification; paediatric eye care and squint surgery; and micro incision cataract surgery treatments. It provides treatment services for vari